Fig. 2: Independent clinical TA-UC cohorts confirm reduced PIK3CA mutation frequency. | Nature Genetics

Fig. 2: Independent clinical TA-UC cohorts confirm reduced PIK3CA mutation frequency.

From: Tamoxifen induces PI3K activation in uterine cancer

Fig. 2: Independent clinical TA-UC cohorts confirm reduced PIK3CA mutation frequency.The alternative text for this image may have been generated using AI.

a, Bar plot of clinical gene panel sequencing for TA-UC and de novo UC; bars represent PIK3CA mutation frequencies; error bars reflect s.d. from the β-distribution; significance analysis by two-sided Fisher’s exact test; numbers in bars indicate mutated tumor count per group. b, Bar plot of clinical WES data for TA-UC and de novo UC; bars represent PIK3CA mutation frequencies; error bars reflect s.d. from the β-distribution; numbers in bars indicate mutated tumor count per group. Significance analysis by two-sided Fisher’s exact test. c, Bar plot of WES data for TA-UC and de novo UC; bars represent PIK3CA and/or PIK3R1 mutation frequencies; error bars reflect s.d. from the β-distribution; numbers in bars indicate mutated tumor count per group. Significance analysis by two-sided Fisher’s exact test.

Back to article page